'Top-class IP litigator' Florence Verhoestraete and Philippe Remels jointly lead the team at NautaDutilh, which is praised by clients for its 'very creative' approach to IP litigation. The group appears before courts across the EU in product liability disputes, in addition to advising on IPOs and competition issues concerning unfair business practices. Verhoestraete is noted for her longstanding expertise in transactional IP issues, including research collaborations and IP assignments, often acting for research centres, start-ups, and large international life sciences companies. Remels has notable knowledge surrounding transactional issues, and is known for handling an array of private financing rounds and general corporate matters.
Testimonials
Collated independently by Legal 500 research team.
‘The Nauta team has great experience in the field of IP litigation, especially for healthcare and life sciences. Their approach is very creative, but based on thorough research about the laws, precedents and recent tendency of the relevant courts. Also, the team has an excellent network with many specialists. With these assets, the Nauta team provides wonderful service to clients.’
‘Florence Verhoestraete is an experienced, top-class IP litigator, forming a team and collaborating. Her view is based on vast and deep experience in IP litigation and she can bridge legal analysis and commercial interests for clients in a creative manner.’
‘Florence Verhoestraete and Tanguy de Haan make a brilliant team and complement each other's skillsets very well. Great knowledge of the life sciences industry and some of its most complex IP matters.’
Key clients
- Abacus Medicine
- Allergan
- Azalea Vision
- Bausch Health companies Inc.
- Cliniques Universitaires Saint-Luc
- GSK
- Johnson & Johnson
- Mediq
- Morrow
- Nyxoah
- Onward Medical
- S-Biomedic
- Suazio
- VIB
- Vico Therapeutics International
Work highlights
- Assisting S-Biomedic's shareholders and Co-Founders with the sale of shares to Beiersdorf.
- Assisting the underwriters in the $1.27bn capital raise of argenx.
- Advising Nyxoah on its $50m at-the-market offering program and on a $15m private placement of new shares, and a $3m sale of new shares under its ATM program.
Practice head
The lawyer(s) leading their teams.
Florence Verhoestraete, Philippe Remels